Maximilian Busch

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Epidermal Growth Factor Receptor

Drug Administration

Coronavirus Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Meineke, Sonja Stelz, Maximilian Busch, Christopher Werlein, Mark Kühnel, Danny D Jonigk, Guus F Rimmelzwaan, Husni Elbahesh
FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections. Viruses 14 (9) (2022)